Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
31 07 2019
Historique:
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 26 3 2020
Statut: epublish

Résumé

Pheochromocytomas and paragangliomas (PCC/PGL) are neuroendocrine tumors of the adrenal medulla and extra-adrenal ganglia which often over-secrete catecholamines leading to cardiovascular morbidity and even mortality. These unique tumors have the highest heritability of all solid tumor types with up to 35-40% of patients with PCC/PGL having a germline predisposition. PURPOSE OF REVIEW: To review the germline susceptibility genes and clinical syndromes associated with PCC/PGL. RECENT FINDINGS: There are over 12 PCC/PGL susceptibility genes identified in a wide range of pathways. Each gene is associated with a clinical syndrome with varying penetrance for both primary and metastatic PCC/PGL and often includes increased risk for additional tumors besides PCC/PGL. Patients with sporadic or hereditary PCC/PGL should be monitored for life given the risk of multiple primary tumors, recurrence, and metastatic disease. All patients with PCC/PGL should be referred for consideration for clinical genetic testing given the high heritability of disease.

Identifiants

pubmed: 31367972
doi: 10.1007/s11886-019-1184-y
pii: 10.1007/s11886-019-1184-y
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

J Urol. 1999 Nov;162(5):1582-6
pubmed: 10524872
Eur J Endocrinol. 1999 Dec;141(6):619-24
pubmed: 10601965
Science. 2000 Feb 4;287(5454):848-51
pubmed: 10657297
Hum Genet. 2000 Feb;106(2):236-43
pubmed: 10746566
Nat Genet. 2000 Nov;26(3):268-70
pubmed: 11062460
Am J Hum Genet. 2001 Jul;69(1):49-54
pubmed: 11404820
Nat Genet. 2002 Apr;30(4):406-10
pubmed: 11865300
JAMA. 2002 Mar 20;287(11):1427-34
pubmed: 11903030
Science. 2002 Jun 7;296(5574):1886-9
pubmed: 12004076
Cancer Cell. 2005 Jan;7(1):77-85
pubmed: 15652751
J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):74-6
pubmed: 16361598
World J Surg. 2006 May;30(5):665-9
pubmed: 16617420
N Engl J Med. 2006 Jun 22;354(25):2729-31
pubmed: 16790714
Hum Mutat. 2007 Feb;28(2):143-9
pubmed: 17024664
Ann N Y Acad Sci. 2006 Aug;1073:47-51
pubmed: 17102071
J Clin Endocrinol Metab. 2008 May;93(5):1573-5
pubmed: 18463350
J Clin Endocrinol Metab. 2009 May;94(5):1541-7
pubmed: 19223516
J Clin Endocrinol Metab. 2009 Jun;94(6):1938-44
pubmed: 19336503
Eur J Endocrinol. 2009 Aug;161(2):355-61
pubmed: 19497985
J Intern Med. 2009 Jul;266(1):19-42
pubmed: 19522823
Endocr Pract. 2009 Jul-Aug;15 Suppl 1:1-20
pubmed: 19632967
Hum Mutat. 2010 Jan;31(1):41-51
pubmed: 19802898
J Clin Endocrinol Metab. 2009 Nov;94(11):4367-71
pubmed: 19808854
J Clin Endocrinol Metab. 2010 Feb;95(2):678-85
pubmed: 19965926
Lancet Oncol. 2010 Apr;11(4):366-72
pubmed: 20071235
Nat Genet. 2010 Mar;42(3):229-33
pubmed: 20154675
Hum Mol Genet. 2010 Aug 1;19(15):3011-20
pubmed: 20484225
Arch Dermatol Res. 2011 Jul;303(5):317-25
pubmed: 21042801
JAMA. 2010 Dec 15;304(23):2611-9
pubmed: 21156949
Clin Cancer Res. 2011 Jan 15;17(2):247-54
pubmed: 21224366
Clin Chem. 2011 Mar;57(3):411-20
pubmed: 21262951
Eur J Hum Genet. 2011 Jun;19(6):617-23
pubmed: 21386872
Nat Genet. 2011 Jun 19;43(7):663-7
pubmed: 21685915
Hum Mol Genet. 2011 Oct 15;20(20):3974-85
pubmed: 21784903
J Clin Endocrinol Metab. 2011 Dec;96(12):E2009-13
pubmed: 21937622
Clin Cancer Res. 2012 May 15;18(10):2828-37
pubmed: 22452945
Genes Dev. 2012 Jun 15;26(12):1326-38
pubmed: 22677546
N Engl J Med. 2012 Sep 6;367(10):922-30
pubmed: 22931260
Clin Endocrinol (Oxf). 2013 Jun;78(6):898-906
pubmed: 23072324
J Mol Med (Berl). 2013 Apr;91(4):507-12
pubmed: 23090011
J Med Genet. 2012 Dec;49(12):768-76
pubmed: 23099648
Blood. 2013 Mar 28;121(13):2563-6
pubmed: 23361906
Hum Mol Genet. 2013 Jun 1;22(11):2169-76
pubmed: 23418310
Ann Surg Oncol. 2013 May;20(5):1444-50
pubmed: 23512077
J Clin Endocrinol Metab. 2014 Feb;99(2):E369-73
pubmed: 24276449
Hum Mol Genet. 2014 May 1;23(9):2428-39
pubmed: 24334765
Hum Mol Genet. 2014 May 1;23(9):2440-6
pubmed: 24334767
Dan Med J. 2013 Dec;60(12):B4763
pubmed: 24355456
Lancet Oncol. 2014 May;15(6):648-55
pubmed: 24745698
J Clin Endocrinol Metab. 2014 Aug;99(8):E1482-6
pubmed: 24758179
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
J Clin Endocrinol Metab. 2014 Oct;99(10):E2046-50
pubmed: 25004247
Oncotarget. 2014 Aug 15;5(15):5873-92
pubmed: 25026295
Ann Surg Oncol. 2015 Jan;22(1):132-8
pubmed: 25047479
BMC Med Genet. 2014 Oct 10;15:111
pubmed: 25300370
Nat Rev Endocrinol. 2015 Feb;11(2):101-11
pubmed: 25385035
Genet Med. 2015 Jan;17(1):70-87
pubmed: 25394175
J Pathol. 2015 May;236(1):78-89
pubmed: 25545346
Nat Commun. 2015 Jan 27;6:6044
pubmed: 25625332
J Natl Cancer Inst. 2015 Mar 11;107(5):null
pubmed: 25766404
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
JAMA Oncol. 2016 Jul 1;2(7):922-8
pubmed: 27011036
Eur J Endocrinol. 2016 Aug;175(2):G1-G34
pubmed: 27390021
Clin Endocrinol (Oxf). 2017 Jan;86(1):141-149
pubmed: 27460956
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
J Cancer Res Clin Oncol. 2017 Aug;143(8):1421-1435
pubmed: 28374168
JAMA Oncol. 2017 Sep 1;3(9):1204-1212
pubmed: 28384794
Eur J Endocrinol. 2017 Aug;177(2):115-125
pubmed: 28490599
Clin Cancer Res. 2017 Jun 15;23(12):e68-e75
pubmed: 28620007
Clin Cancer Res. 2017 Oct 15;23(20):6315-6324
pubmed: 28720665
Endocr Relat Cancer. 2018 Feb;25(2):T1-T13
pubmed: 29142004
J Clin Endocrinol Metab. 2018 Feb 1;103(2):438-445
pubmed: 29177515
J Med Genet. 2018 Jun;55(6):384-394
pubmed: 29386252
Cancer Res. 2018 Apr 15;78(8):1914-1922
pubmed: 29431636
Genet Med. 2018 Dec;20(12):1644-1651
pubmed: 29740169
Genet Med. 2018 Jul;20(7):671-682
pubmed: 30006586
Genet Med. 2018 Dec;20(12):1652-1662
pubmed: 30008476
Am J Hum Genet. 2019 Apr 4;104(4):651-664
pubmed: 30929736

Auteurs

Lauren Fishbein (L)

Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, 12801 E. 17th Ave, MS 8106, Aurora, CO, 80045, USA. lauren.fishbein@ucdenver.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH